What is the recommended N-acetylcysteine (NAC) infusion dose for traumatic liver injury?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

N-Acetylcysteine (NAC) Infusion Protocol for Traumatic Liver Injury

The recommended N-acetylcysteine (NAC) infusion dose for traumatic liver injury is a loading dose of 150 mg/kg in 5% dextrose over 15 minutes, followed by a maintenance dose of 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours. 1

Rationale for NAC in Traumatic Liver Injury

  • NAC serves as a hepatoprotective agent in traumatic liver injury by replenishing glutathione stores and providing antioxidant effects, similar to its mechanism in acetaminophen toxicity 1, 2
  • NAC administration is recommended in any case of acute liver failure where hepatocyte damage is occurring or imminent, regardless of etiology 1
  • NAC has been shown to decrease disease progression in hepatic failure, with studies demonstrating significant reductions in mortality, cerebral edema, and need for inotropic support 1

Administration Protocol

Intravenous Administration (Preferred in Trauma)

  • Loading dose: 150 mg/kg in 5% dextrose over 15 minutes 1, 2
  • Maintenance dose: 50 mg/kg over 4 hours, followed by 100 mg/kg over 16 hours 1, 2
  • Continue administration until liver function tests normalize or clinical improvement is observed 1

Oral Administration (If IV access is limited)

  • Loading dose: 140 mg/kg by mouth or nasogastric tube diluted to 5% solution 1
  • Maintenance dose: 70 mg/kg by mouth every 4 hours for 17 doses 1
  • Note: In trauma patients with active bleeding or altered mental status, oral administration may be precluded 1

Timing Considerations

  • NAC should be administered as early as possible following traumatic liver injury 1, 3
  • Maximum benefit is observed when NAC is initiated within 8 hours of injury, but it may still provide benefit when started up to 24 hours after injury 2, 3
  • Caution: Initiation of NAC treatment >24 hours after hospital admission may potentially be harmful in critically ill patients 4

Monitoring During Treatment

  • Monitor liver function tests (AST, ALT, alkaline phosphatase, total bilirubin) 1, 5
  • Monitor coagulation parameters (INR, PT) 1, 5
  • Monitor for adverse reactions, particularly allergic reactions which may include urticaria or bronchospasm 1

Management of Adverse Reactions

  • For allergic reactions: discontinue infusion, administer antihistamines, and provide epinephrine for bronchospasm if needed 1
  • Common adverse events include anaphylactic reactions with IV administration and gastrointestinal symptoms with oral administration 3

Special Considerations

  • NAC has shown benefit in non-acetaminophen-induced acute liver failure, with one study demonstrating 96.4% transplant-free survival in patients receiving NAC compared to 23.3% in controls 6
  • NAC (150 mg/kg) has demonstrated protective effects in ischemia-reperfusion liver injury models, which may be relevant in trauma settings 7
  • NAC administration should be considered even in cases where the exact mechanism of liver injury is unclear, given its favorable risk-benefit profile 8

Pitfalls and Caveats

  • Do not delay NAC administration while awaiting complete diagnostic workup in cases of severe traumatic liver injury 1
  • Standard acetaminophen toxicity nomograms are not applicable to traumatic liver injury 5
  • Be vigilant for signs of anaphylactic reactions, particularly during the loading dose administration 1, 3
  • Consider potential drug interactions, particularly in polytrauma patients receiving multiple medications 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.